Fundraising Fox

Rgenix

New York, US · Delaware corporation · 2 known investors

rgenix.com
Biotech

Founders & leadership

MTMasoud Tavazoie
Masoud TavazoieChief Scientific Officer
DDDavid Darst
David DarstChief Operating Officer
IKIsabel Kurth
Isabel KurthVice President - Research

Board

SS
Shahram Seyedin-NoorExecutive Chairman
NC
Nancy ChangBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$141.9M disclosed across 5 rounds · 2015–2022

$55.1MraisedAug 2022 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dieter WeinandDirector
  • Jue PuDirector
  • Raymond CamahortDirector
  • Jack NielsenDirector
  • Eric RowinskyDirector
  • Antoine PapiernikDirector
  • Masoud TavazoieExecutive Officer, Director
  • Peter Van VlasselaerDirector
  • David DarstExecutive Officer
  • Michael GinderDirector
Offering amount
$55.1M
Amount sold
$55.1M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6MraisedFeb 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jue PuDirector
  • Nancy ChangDirector
  • Peter Van VlasselaerDirector
  • Antoine PapiernikDirector
  • Nilesh KumarDirector
  • Saeed TavazoieExecutive Officer, Director
  • Eric RowinskyExecutive Officer, Director
  • David DarstExecutive Officer
  • Masoud TavazoieExecutive Officer, Director
Offering amount
$11M
Amount sold
$6M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$39.8MraisedOct 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jue PuDirector
  • Nancy ChangDirector
  • Masoud TavazoieExecutive Officer, Director
  • David DarstExecutive Officer, Director
  • Antoine PapiernikDirector
  • Eric RowinskyDirector
  • Saeed TavazoieExecutive Officer, Director
  • Nilesh KumarDirector
Offering amount
$39.8M
Amount sold
$39.8M
Sales commissions
$1.1M
Placement agents
Jefferies LLC
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$33MraisedJun 2016 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David DarstExecutive Officer
  • Eric RowinskyExecutive Officer, Director
  • Nancy ChangDirector
  • Antoine PapiernikDirector
  • Nilesh KumarDirector
  • Masoud TavazoieExecutive Officer, Director
Offering amount
$33M
Amount sold
$33M
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8MraisedAug 2015 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David DarstExecutive Officer, Director
  • Shahram Seyedin-NoorExecutive Officer, Director
  • Nancy ChangDirector
  • Isabel KurthExecutive Officer, Director
  • Masoud TavazoieExecutive Officer, Director
Offering amount
$8M
Amount sold
$8M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1.6M
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$199.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Rgenix?
Rgenix was founded by Masoud Tavazoie.
Who are Rgenix's investors?
Rgenix's investors include +ND Capital, Sofinnova Partners.
How much funding has Rgenix raised?
Rgenix has disclosed $141.9M raised across 5 rounds.
Where is Rgenix headquartered?
Rgenix is headquartered in New York, US.